Efficacy and safety of human umbilical cord‑derived mesenchymal stem cells(hUC‑MSC PLEB001)for the treatment of grade II–IV steroid‑refractory acute graft‑versus‑host disease:a study protocol for a multicenter,randomized, double‑blind, placebo‑controlled,phase II trial